B-cells produce antibodies to attack bacteria ... There is some overlap in the definitions for some subtypes, such as T-lymphoblastic lymphoma/leukemia and adult T-cell lymphoma/leukemia.

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Circulating tumor DNA as measurable residual disease in aggressive B-cell lymphoma: a narrative review ... Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Stripping and reprobing the membrane with an antibody that recognized STAT5A and B showed differential STAT5 protein expression for each tumor (Figure 1c). To further demonstrate the presence and ...

The Scottish Medicines Consortium has backed NHS funding for Gilead’s CAR-T therapy Yescarta for B-cell lymphomas ... cleared for use in acute lymphoblastic lymphoma (ALL).

The potential impact of this form of therapy in pediatric precursor B-lineage acute lymphoblastic leukemia ... tested in patients with non-Hodgkin's lymphoma (NHL), but not in patients with ...

Pet owners can bring in their cats and dogs Saturday to Wizard of Paws for nail trims that will benefit a local girl battling ...

SAN DIEGO — A bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia, findings ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic ... two types: B-ALL and T-ALL ...